Summary
This 8-K filing from HCA Healthcare, Inc. (HCA), dated March 11, 2014, reports on a material amendment to its existing credit facility. Specifically, HCA Inc., a subsidiary, entered into an Amended and Restated Credit Agreement (ABL Restatement Agreement) that extends the maturity date of its revolving credit commitments to March 7, 2019. This refinancing provides greater financial flexibility and extends the company's debt obligations. Key amendments to the ABL Agreement include provisions allowing for increased debt incurrence by non-borrower restricted subsidiaries (up to $2.0 billion), removal of certain restrictions on assumed debt, an increase in the basket for foreign subsidiary debt, and a modification to the disposition basket for transactions within a rolling five-year period. These changes suggest a proactive approach by HCA to manage its capital structure and enhance its borrowing capacity.
Key Highlights
- 1Extended revolving credit facility maturity date to March 7, 2019.
- 2Increased flexibility for HCA to incur debt through non-borrower restricted subsidiaries up to $2.0 billion.
- 3Removed a restriction on assumed debt related to Scheduled Inside Payments.
- 4Increased the allowance for debt incurred by foreign subsidiaries from 2.5% to 5.0% of total assets.
- 5Modified the general disposition basket to apply over a rolling five-year period.
- 6The agreement was entered into by HCA Inc., a wholly-owned subsidiary, with Bank of America, N.A. as administrative and collateral agent.